FDA Inspection 1122030 — NDX Pacific
The FDA completed an inspection of NDX Pacific on March 12, 2020 in Hawthorne, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 12, 2020
- Fiscal Year
- 2020
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Hawthorne, CA (United States)